Skip to main content
SpringerLink
Log in

β2-Adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium

Quantitative discrepancies with binding and adenylate cyclase stimulation

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Experiments were designed to unravel the relative contribution of β1- and β2-adrenoceptors to the positive inotropic effects of adrenaline and noradrenaline in isolated tissues of left ventricular myocardium of man. We also analyzed relationships between the fractions of human left ventricular β1- and β2-adrenoceptors, estimated from binding assays, and stimulation of adenylate cyclase and contractile force by adrenaline and noradrenaline. 1) Selective blockade of β2-adrenoceptors by erythro(±)-(α-methyl-indan-4-yloxy)-3-isopropylaminobutan-2-ol (ICI 118,551) attenuated the increase of contractile force caused by adrenaline but not by noradrenaline, suggesting some involvement of β2-adrenoceptors. Selective blockade of β2-adrenoceptors without affecting α1-adrenoceptors still enabled both adrenaline and noradrenaline to cause maximum possible increases of contractile force through β1-adrenoceptors. 2) A direct involvement of β2-adrenoceptors became manifest by selectively antagonizing β1-adrenoceptors by 1-[2((3-carbamoyl-4-hydroxy)phenoxy)ethylamino]3-[4(1-methyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol (CGP 20712 A) without affecting β2-adrenoceptor. β2-adrenoceptors can mediate half of the maximum increase of contractile force elicited by low concentrations of adrenaline and also contribute to the increase of contractile force caused by high concentrations of noradrenaline. 3) β-adrenoceptors were labelled in membrane particles with 3H-(−)-bupranolol in the absence (β1 & β2) and presence of 500 nmol/l CGP 20712 A (β2). 71 % of the β-adrenoceptors Were β1 and 29% β2. Binding inhibition experiments with CGP 20712 A and ICI 118,551 yielded 74% β1 and 26% β2-4) With the help of ICI 118,551 and CGP 20712 A it was found that, in membrane particles, 33–36% and 64–67% of maximum stimulation of the adenylate cyclase by noradrenaline was mediated through β1- and β2-adrenoceptors, respectively. Adrenaline caused 11–25% and 75–89% of maximum cyclase stimulation through β1- and β2-adrenoceptors, respectively. 5) The contribution of β1- and β2-adrenoceptors to the positive inotropic effects of adrenaline and noradrenaline cannot be inferred straightforwardly from biochemical estimates of receptor fractions and fractional adenylate cyclase stimulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bilski A, Halliday SE, Fitzgerald JD, Wale JL (1983) The pharmacology of a β2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol 5:430–437

    Google Scholar 

  • Blinks JR (1965) Convenient apparatus for recording contractions of isolated muslce. J Appl Physiol 20:755–757

    Google Scholar 

  • Bristow MR, Ginsburg R (1986) β2 receptors on myocardial cells in human ventricular myocardium. Am J Cardiol 57:3F-6F

    Google Scholar 

  • Brodde OE, Karad K, Zerkowski HR, Rohm N, Reidemeister JC (1983) Coexistence of β1- and β2-adrenoceptors in human right atrium. Direct identification by (±)-125iodocyanopindolol binding. Circ Res 53:752–758

    Google Scholar 

  • Carlsson E, Ablad B, Brandstrom A, Carlsson B (1972) Differential blockade of the chronotropic effects of various adrenergic stimuli in the cat heart. Life Sci 11:953–958

    Google Scholar 

  • Dooley DJ, Bittiger H (1984) A specific β1-adrenoceptor antagonist and useful tool for quantitating β1- and β2-adrenoceptors. IUPHAR 9th International Congress of Pharmacology. London, Proceedings 1009P

  • Ehle B, Lemoine H, Kaumann AJ (1985) Improved evaluation of binding of ligands to membranes containing several receptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 331: 52–59

    Google Scholar 

  • Gille E, Lemoine H, Ehle B, Kaumann AJ (1985) The affinity of (−)-propranolol for β1- and β2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (−)-noradrenaline and (−)-adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 331:60–70

    Google Scholar 

  • Golf S, Myhre E, Abdelnoor M, Andersen D, Hansson V (1985) Hypertrophic cardiomyopathy characterised by β-adrenoceptor density, relative amount of β-adrenoceptor subtypes and adenylate cyclase activity. Cardiovasc Res 19:693–699

    Google Scholar 

  • Hayes JS, Brunton LL, Mayer SE (1980) Selective activation of particulate cAMP-dependent protein kinase by isoproterenol and prostaglandin E1. J Biol Chem 255:5113–5119

    Google Scholar 

  • Hedberg A, Minneman KP, Molinoff PB (1980) Differential distribution of β1 and β2 adrenergic receptors in cat and guinea pig heart. J Pharmacol Exp Ther 212:503–508

    Google Scholar 

  • Heitz A, Schwartz J, Velly J (1983) β-adrenoceptors of the human myocardium — determination of β1 and β2 subtypes by radioligand binding. Br J Pharmacol 33:467–473

    Google Scholar 

  • Kaumann AJ (1970) Adrenergic receptors in heart muscle: Relation among factors influencing the sensitivity of the cat papillary muscle to catecholamines. J Pharmacol Exp Ther 173:383–398

    Google Scholar 

  • Kaumann AJ (1986) The β1-adrenoceptor antagonist CGP 20712 A unmasks β2-adrenoceptors activated by (−)-adrenaline in rat sinoatrial node. Naunyn-Schmiedeberg's Arch Pharmacol 333:73–76

    Google Scholar 

  • Kaumann AJ, Birnbaumer L (1974a) Characteristics of the adrenergic receptor coupled to myocardial adenylyl cyclase. Stereospecificity and determination of apparent affinity constants for beta blockers. J Biol Chem 249:7874–7885

    Google Scholar 

  • Kaumann AJ, Birnbaumer L (1974b) Prostaglandin E1 action on sinus pacemaker and adenylyl cyclase in kitten myocardium. Nature 251:515–517

    Google Scholar 

  • Kaumann AJ, Lemoine H (1985) Direct labelling of myocardial β1-adrenoceptors. Comparison of binding affinity of 3H-(−)-bisoprolol with its blocking potency. Naunyn-Schmiedeberg's Arch Pharmacol 331:27–39

    Google Scholar 

  • Kaumann AJ, Lobnig BM (1986) Mode of action of (−)-pindolol on feline and human myocardium. Br J Pharmacol 89:207–218

    Google Scholar 

  • Kaumann AJ, Lemoine H, Morris TH, Schwederski U (1982) An initial characterization of human heart β-adrenoceptors and their mediation of the positive inotropic effects of catecholamines. Naunyn-Schmiedeberg's Arch Pharmacol 319:216–221

    Google Scholar 

  • Kaumann AJ, Morris TH, Bojar H (1983) Heart β-adrenoceptors on the functional role of heterogeneous binding sites. J Recep Res 3:61–70

    Google Scholar 

  • Kaumann AJ, Lemoine H, Ehle B (1985) Different involvement of β1- and β2-adrenoceptors in the effects of (−)-noradrenaline and (−)-adrenaline in several heart regions of cat, guinea pig and man. Pflügers Arch 403:R27

    Google Scholar 

  • Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG (1967) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214:597–598

    Google Scholar 

  • Lemoine H, Ehle B, Kaumann AJ (1985a) Direct labelling of β2-adrenoceptors: Comparison of binding potency of 3H-ICI 118,551 ad blocking potency of ICI 118,551. Naunyn-Schmiedeberg's Arch Pharmacol 331:40–51

    Google Scholar 

  • Lemoine H, Ehle B, Schwederski U, Kaumann AJ (1985b) The relationship between inotropic effects, receptor-binding and adenylate cyclase stimulation of catecholamines in human heart. Pfügers Arch 405:R13

    Google Scholar 

  • Lemoine H, Ehle B, Kaumann AJ (1985c) On the participation of β1- and β2-adrenoceptors in the relaxation of calf trachea caused by (−)-noradrenaline, (−)-adrenaline and (±)-fenoterol. Naunyn-Schmiedeberg's Arch Pharmacol 329:R321

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • McCaffey PM, Riddell JG, Shanks RG (1986) The selectivity of the partial agonist activity of xamoterol in man measured by its effects in the presence and absence of ICI 118,551. Br J Pharmacol (in press)

  • Morris TH, Sandrock K, Kaumann AJ (1981) 3H-(−)-Bupranolol, a new β-adrenoceptor radioligand: Characterization of its binding to kitten heart β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 317:19–25

    Google Scholar 

  • Mügge A, Posselt D, Reimer U, Schmitz M, Scholz H (1985) Effects of beta2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium. Klin Wochenschr 63:26–31

    Google Scholar 

  • Robberecht P, Delhaye M, Taton G, De Neef P, Waelbroeck M, De Smet JM, Leclerc JL, Chatelain P, Christophe J (1983) The human heart β-adrenergic receptors. I. Heterogeneity of the binding sites: Presence of 50% β1-adrenergic receptors. Mol Pharmacol 24:169–173

    Google Scholar 

  • Salomon Y, Londos C, Rodbell M (1974) A highly sensitive adenylate cyclase assay. Anal Biochem 58:541–548

    Google Scholar 

  • Schütz W, Freissmuth M, Hausleithner V, Böck M, Nees S (1986) Cardiac ventricular β2-adrenoceptors in guinea pig and rats are localized on the coronary endothelium. Naunyn-Schmiedeberg's Arch Pharmacol 334:R47

    Google Scholar 

  • Stiles GL, Taylor S, Lefkowitz RJ (1983) Human cardiac β-adrenergic receptors: Subtype heterogeneity delineated by direct radioligand binding. Life Sciences 33:467–473

    Google Scholar 

  • Tomlins B, Harding SE, Kirby MS, Poole-Wilson PA, Williams AJ (1986) Contamination of a cardiac sarcolemmal preparation with endothelial plasma membranes. Biochem Biophys Acta 856:1, 137–143

    Google Scholar 

  • Waelbroeck M, Taton G, Delhaye M, Chatelain P, Camus JC, Pochet R, Leclerc JL, De Smet JM, Robberecht P, Christophe J (1983) The human heart beta-adrenergic receptors. II. Coupling of beta2-adrenergic receptors with the adenylate cyclase system. Mol Pharmacol 24:174–182

    Google Scholar 

  • Zerkowski HR, Ikezono K, Rohm N, Reidemeister JC, Brodde OE (1986) Human myocardial β-adrenoceptors: demonstration of both β1- and β2-adrenoceptors mediating contractile responses to β-agonists on the isolated right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 332:142–147

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Physiology, Physiological Institute, University of Düsseldorf, D-4000, Dusseldorf, Federal Republic of Germany

    A. J. Kaumann & H. Lemoine

Authors
  1. A. J. Kaumann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Lemoine
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Send offprint requests to A. J. Kaumann, ICI Pharmaceutical Division, Mereside Alderley Park, Macclesfield, Cheshire SK10 4TG, UK

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaumann, A.J., Lemoine, H. β2-Adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Naunyn-Schmiedeberg's Arch Pharmacol 335, 403–411 (1987). https://doi.org/10.1007/BF00165555

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00165555

Key words

Search

Navigation